Hydroxyurea Clinical Trials
12 recruitingDrug
Phase 25Phase 14Phase 33Phase 41
Showing 1–12 of 12 trials
Recruiting
Phase 3
Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)
Essential Thrombocythemia
Merck Sharp & Dohme LLC300 enrolled166 locationsNCT06456346
Recruiting
Phase 3
Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera
Polycythemia Vera
Italfarmaco220 enrolled90 locationsNCT06093672
Recruiting
Phase 1
Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Recurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
Roswell Park Cancer Institute26 enrolled1 locationNCT06871410
Recruiting
Phase 2
Pacritinib vs. Hydroxyurea in Advanced Proliferative Chronic Myelomonocytic Leukemia
Leukemia, Myelomonocytic, Chronic
Theradex66 enrolled4 locationsNCT07033598
Recruiting
Phase 4
Stroke Prevention in Nigeria 2 Trial
StrokeSickle Cell Disease
Vanderbilt University Medical Center220 enrolled2 locationsNCT06526117
Recruiting
Phase 1
Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer
Head and Neck CarcinomaHead and Neck CancerHead and Neck Squamous Cell Carcinoma+2 more
University of Chicago30 enrolled1 locationNCT05526924
Recruiting
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
Lactating Women on Select DOIBreastfed Infants of Mothers on Select DOI
Duke University1,600 enrolled22 locationsNCT03511118
Recruiting
Phase 1Phase 2
Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure
Idiopathic Pulmonary FibrosisEmphysema or COPD
Paul Szabolcs8 enrolled2 locationsNCT03500731
Recruiting
Phase 2
Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
Juvenile Rheumatoid Arthritis (JRA)Primary Immunodeficiency (PID)Congenital Bone Marrow Failure Syndromes+4 more
Paul Szabolcs100 enrolled1 locationNCT01962415
Recruiting
Phase 2
A Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler Velocities in Pediatric Patients With Sickle Cell Disease Who Are at Increased Risk for Primary Stroke
Sickle Cell Disease
Forma Therapeutics, Inc.27 enrolled9 locationsNCT05953584
Recruiting
Phase 1Phase 2
T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias
Sickle Cell Anemia
Paul Szabolcs5 enrolled1 locationNCT03653338
Recruiting
Phase 3
Promoting Utilization and Safety of Hydroxyurea Using Precision in Africa
Sickle Cell DiseaseSickle Cell Anemia in Children
Brown University400 enrolled1 locationNCT05285917